Go back to Resources
Safety and immunogenicity of env 2-3, a human immunodeficiency virus type 1 candidate vaccine, in combination with a novel adjuvant, MTP-PE/MF59,
1996
Journal Article
Authors:
Secondary:
AIDS Res Hum Retroviruses,
Volume:
12
Pagination:
683-93